Amneal Pharmaceuticals (NYSE:AMRX) Updates FY 2023 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided EPS guidance of $0.45-$0.55 for the period, compared to the consensus EPS estimate of $0.47. The company issued revenue guidance of $2.30 billion-$2.40 billion, compared to the consensus revenue estimate of $2.32 billion. […]
Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) had its price objective raised by stock analysts at Barclays from $4.00 to $5.00 in a research report issued on Friday, FlyOnTheWall reports. Barclays‘s price objective indicates a potential upside of 21.65% from the stock’s current price. A number of other brokerages have also weighed in on AMRX. […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) has received a consensus rating of “Moderate Buy” from the four analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price objective among brokers that […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) shot up 4.8% on Friday . The company traded as high as $2.83 and last traded at $2.83. 300,636 shares traded hands during trading, a decline of 70% from the average session volume of 990,237 shares. The stock had previously closed at $2.70. Analyst Ratings Changes A number […]